Cargando…

Effects of Finerenone on Cardiovascular and Chronic Kidney Diseases: A New Weapon against Cardiorenal Morbidity and Mortality—A Comprehensive Review

Patients with cardiovascular disease (CVD) and chronic kidney disease (CKD) show high rates of cardiorenal outcomes. In addition, the progression towards renal failure and cardiovascular events rises as CKD worsens. Several studies suggest that the activation of the mineralocorticoid receptor (MR) i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piccirillo, Francesco, Liporace, Paola, Nusca, Annunziata, Nafisio, Vincenzo, Corlianò, Andrea, Magarò, Francesca, Antonelli Incalzi, Raffaele, Ussia, Gian Paolo, Grigioni, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299623/ https://www.ncbi.nlm.nih.gov/pubmed/37367401 http://dx.doi.org/10.3390/jcdd10060236

Ejemplares similares

Novel Antidiabetic Agents and Their Effects on Lipid Profile: A Single Shot for Several Cardiovascular Targets
por: Piccirillo, Francesco, et al.
Publicado: (2023)

Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental Study
por: Nusca, Annunziata, et al.
Publicado: (2021)

Cardiorenal benefits of finerenone: protecting kidney and heart
por: González-Juanatey, José R., et al.
Publicado: (2023)

Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data
por: Nusca, Annunziata, et al.
Publicado: (2022)

Nonsteroidal Mineralocorticoid Receptor Antagonist (Finerenone) in Cardiorenal Disease
por: Shah, Monarch, et al.
Publicado: (2023)

The Pivotal Role of Invasive Functional Assessment in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA)
por: Mangiacapra, Fabio, et al.
Publicado: (2021)

Percutaneous Repair of Atrial Functional Tricuspid Regurgitation in Cardiac Amyloidosis: Combining Linear With Lateral Thinking
por: Nusca, Annunziata, et al.
Publicado: (2022)

In Stent Neo-Atherosclerosis: Pathophysiology, Clinical Implications, Prevention, and Therapeutic Approaches
por: Nusca, Annunziata, et al.
Publicado: (2022)

Functional Mitral and Tricuspid Regurgitation across the Whole Spectrum of Left Ventricular Ejection Fraction: Recognizing the Elephant in the Room of Heart Failure
por: Cammalleri, Valeria, et al.
Publicado: (2023)

Invasive Assessment of Coronary Microvascular Function
por: Mangiacapra, Fabio, et al.
Publicado: (2021)

Arrhythmias after COVID-19 Vaccination: Have We Left All Stones Unturned?
por: Cocco, Nino, et al.
Publicado: (2023)

Oxidative Stress Management in Cardiorenal Diseases: Focus on Novel Antidiabetic Agents, Finerenone, and Melatonin
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes
por: Ruilope, Luis M., et al.
Publicado: (2022)

Fractional Flow Reserve-Guided Coronary Revascularization: Evidence from Randomized and Non-Randomized Studies
por: Paolucci, Luca, et al.
Publicado: (2022)

Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention
por: Nusca, Annunziata, et al.
Publicado: (2019)

Platelet Effects of Anti-diabetic Therapies: New Perspectives in the Management of Patients with Diabetes and Cardiovascular Disease
por: Nusca, Annunziata, et al.
Publicado: (2021)

Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease
por: Bernardini, Federico, et al.
Publicado: (2023)

Tricuspid Valve Geometrical Changes in Patients with Functional Tricuspid Regurgitation: Insights from a CT Scan Analysis Focusing on Commissures
por: Cammalleri, Valeria, et al.
Publicado: (2023)

Novel Computed Tomography Variables for Assessing Tricuspid Valve Morphology: Results from the TRIMA (Tricuspid Regurgitation IMAging) Study
por: Cammalleri, Valeria, et al.
Publicado: (2022)

Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results
por: Agarwal, Rajiv, et al.
Publicado: (2021)

Network Meta-Analysis on the Effects of SGLT2 Inhibitors Versus Finerenone on Cardiorenal Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease
por: Zhao, Li-Min, et al.
Publicado: (2022)

New Guideline-Directed Treatments for Heart Failure: Navigating Through the Multiple Turns of Everyday Clinical Practice
por: Paolucci, Luca, et al.
Publicado: (2022)

Transcatheter Tricuspid Valve Therapy: From Anatomy to Intervention
por: Cammalleri, Valeria, et al.
Publicado: (2021)

The Role of Finerenone in the Management of Diabetic Nephropathy
por: Veneti, Stavroula, et al.
Publicado: (2021)

Potassium management with finerenone: Practical aspects
por: Wanner, Christoph, et al.
Publicado: (2022)

Acute Childhood Cardiorenal Syndrome and Impact of Cardiovascular Morbidity on Survival
por: Olowu, Wasiu A.
Publicado: (2011)

Redefying the therapeutic strategies against cardiorenal morbidity and mortality: Patient phenotypes
por: Bacharaki, Dimitra, et al.
Publicado: (2023)

The Pharmacokinetics of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone
por: Heinig, Roland, et al.
Publicado: (2023)

Discriminative and predictive properties of disease-specific and generic health status indexes in elderly COPD patients
por: Conte, Maria E, et al.
Publicado: (2008)

Does mild COPD affect prognosis in the elderly?
por: Pedone, Claudio, et al.
Publicado: (2010)

Percutaneous treatment of a CTO in an anomalous right coronary artery: A rupture paved the way for new insights
por: Cocco, Nino, et al.
Publicado: (2022)

Polypharmacy in elderly patients at discharge from the acute care hospital
por: Corsonello, Andrea, et al.
Publicado: (2007)

Enantioselective Total Synthesis of (−)‐Finerenone Using Asymmetric Transfer Hydrogenation
por: Lerchen, Andreas, et al.
Publicado: (2020)

Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study
por: Ruilope, Luis M, et al.
Publicado: (2022)

The Cardiorenal Syndrome
por: Rosner, Mitchell H., et al.
Publicado: (2011)

Cardiorenal syndrome
por: Schetz, Miet
Publicado: (2009)

Cardiorenal syndrome
por: Ye, Wen Qing Wendy, et al.
Publicado: (2023)

Rationale and design of an investigator-initiated, multicenter, prospective, placebo-controlled, double-blind, randomized trial to evaluate the effects of finerenone on vascular stiffness and cardiorenal biomarkers in type 2 diabetes and chronic kidney disease (FIVE-STAR)
por: Tanaka, Atsushi, et al.
Publicado: (2023)

Depression and drug utilization in an elderly population
por: Antonelli Incalzi, Raffaele, et al.
Publicado: (2005)

Single-territory incomplete surgical revascularization improves regional wall motion of remote ventricular areas: results from a propensity-matched study
por: Spadaccio, Cristiano, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6ipbbop5cfnj0tgrtf317m21be